Samer Al Hadidi, Associate Professor at UAMS – University of Arkansas for Medical Sciences, posted on X:
“Check our recent editorial discussing AQUILA study.
Daratumumab for high-risk smoldering multiple myeloma – are we there yet?”
Authors: Bhavesh Mohan Lal, Samer Al Hadidi
Read more posts featuring Myeloma at OncoDaily.com.